Stoke Therapeutics, Inc. Banner Image

Stoke Therapeutics, Inc.

  • Ticker STOK
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Stoke Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in Bedford, Massachusetts
Stoke Therapeutics (Nasdaq: STOK), is a clinical-stage biotechnology company pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression to restore target proteins to near normal levels. Stoke aims to develop the first precision medicine platform to target the underlying cause of a broad spectrum of genetic diseases in whichMore the patient has one healthy copy of a gene and one mutated copy that fails to produce a protein essential to health. These diseases, in which loss of approximately 50% of normal protein expression causes disease, are called autosomal dominant haploinsufficiencies. Stoke is headquartered in Bedford, Massachusetts with offices in Cambridge, Massachusetts.
4.8 / 5.0 (266)

Stoke Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 266 reviews.

Stoke Therapeutics, Inc.

Most Recent Annual Report

Stoke Therapeutics, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Stoke Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!